Does OMALIZUMAB Cause Bronchial secretion retention? 171 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 171 reports of Bronchial secretion retention have been filed in association with OMALIZUMAB (Omalizumab-igec). This represents 0.3% of all adverse event reports for OMALIZUMAB.
171
Reports of Bronchial secretion retention with OMALIZUMAB
0.3%
of all OMALIZUMAB reports
0
Deaths
126
Hospitalizations
How Dangerous Is Bronchial secretion retention From OMALIZUMAB?
Of the 171 reports, 126 (73.7%) required hospitalization, and 8 (4.7%) were considered life-threatening.
Is Bronchial secretion retention Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OMALIZUMAB. However, 171 reports have been filed with the FAERS database.
What Other Side Effects Does OMALIZUMAB Cause?
No adverse event (9,736)
Asthma (9,354)
Urticaria (9,231)
Off label use (9,199)
Dyspnoea (8,323)
Drug ineffective (6,747)
Cough (5,926)
Pruritus (5,224)
Fatigue (5,053)
Malaise (4,820)
What Other Drugs Cause Bronchial secretion retention?
ALBUTEROL (374)
TIOTROPIUM (295)
PREDNISONE (268)
MONTELUKAST (240)
MEPOLIZUMAB (209)
BUDESONIDE (182)
FUROSEMIDE (169)
BISOPROLOL (163)
BUDESONIDE\FORMOTEROL (156)
ACETAMINOPHEN (151)
Which OMALIZUMAB Alternatives Have Lower Bronchial secretion retention Risk?
OMALIZUMAB vs OMAVELOXOLONE
OMALIZUMAB vs OMBITASVIR
OMALIZUMAB vs OMBITASVIR\PARITAPREVIR\RITONAVIR
OMALIZUMAB vs OMEGA-3-ACID ETHYL ESTERS
OMALIZUMAB vs OMEGA-3-CARBOXYLIC ACIDS